Site Listing

Please choose the site that is most convenient for you

Study Name: Maximum Tolerated Dose Study of Belinostat (PXD-101)in Combination With Paclitaxel Plus Carboplatin in Chemotherapy-Naive Patients With Stage IV Non-S
5 locations found